Tazobactam/piperacillin dominates in intra-abdominal infection

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.303, 2001-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tazobactam/piperacillin dominates in intra-abdominal infection

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection

By Dietrich E.S.   Schubert B.   Ebner W.   Daschner F.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 79-94

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of piperacillin-tazobactam

By Hayashi Yoshiro   Roberts Jason A   Paterson David L   Lipman Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1017-1031

Informa Healthcare

Access to resources Recommend Favorite

Intra-abdominal infections

By Minton Jane   Stanley Philip  

Clinical Medicine, Vol. 4, Iss. 6, 2004-11 ,pp. : 519-523

Royal College Of Physicians

Access to resources Recommend Favorite

Piperacillin/tazobactam: Myelosuppression: case report

By  

Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite